RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
194 hedge funds and large institutions have $3.75B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 69 increasing their positions, 66 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 40
44% less call options, than puts
Call options by funds: $30.4M | Put options by funds: $54.7M
Holders
194
Holding in Top 10
7
Calls
$30.4M
Puts
$54.7M
Top Buyers
| 1 | +$107M | |
| 2 | +$97.5M | |
| 3 | +$92.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$29.6M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$22.3M |
Top Sellers
| 1 | -$35.7M | |
| 2 | -$32.8M | |
| 3 | -$24M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$22.5M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$18M |